This content is restricted to members.
To view our premium content, sign up for a membership:
This content is restricted to members.
To view our premium content, sign up for a membership:
1. Yki-Järvinen H. Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome. The Lancet Diabetes & Endocrinology. 2014;2(11):901-910.
2. Kotronen A, Yki-Järvinen H. Fatty Liver: A Novel Component of the Metabolic Syndrome. Arteriosclerosis, Thrombosis, and Vascular Biology. 2008;28(1):27-38.
3. Summers L, Fielding B, Bradshaw H, Ilic V, Beysen C, Clark M et al. Substituting dietary saturated fat with polyunsaturated fat changes abdominal fat distribution and improves insulin sensitivity. Diabetologia. 2002;45(3):369-377.
4. Park Y, Harris W. Omega-3 fatty acid supplementation accelerates chylomicron triglyceride clearance. Journal of Lipid Research. 2002;44(3):455-463.
5. Mostad I, Bjerve K, Bjorgaas M, Lydersen S, Grill V. Effects of n−3 fatty acids in subjects with type 2 diabetes: reduction of insulin sensitivity and time-dependent alteration from carbohydrate to fat oxidation. The American Journal of Clinical Nutrition. 2006;84(3):540-550.
6. Umpleby M, Fielding B. Stable Isotopes in Nutrition Research. In: Lovegrove J, Hodson L, Sharma S, Lanham-New S, ed. by. Nutrition Research Methodologies. 1st ed. John Wiley & Sons Ltd; 2015. p. p. 262.